Inventor · disambiguated record
Cheng Cheng
Also filed as: CHENG CHENG TANG
21 granted patents·18 pending applications·56 citations·filing 2002–2024
93Inventor score
Top patents by PatentIndex Score
39 records- 0193US10961283B2Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigensUS HEALTH·Filed 2017·Granted Mar 30, 2021·11 cites·34 claims
- 0293US10400015B2Recombinant HIV-1 envelope proteins and their useUS HEALTH·Filed 2015·Granted Sep 3, 2019·10 cites·51 claims
- 0392US11939356B2Self-assembling insect ferritin nanoparticlesUS HEALTH·Filed 2021·Granted Mar 26, 2024·2 cites·19 claims
- 0490US11459360B2Recombinant HIV-1 envelope proteins and their useUS HEALTH·Filed 2019·Granted Oct 4, 2022·4 cites·30 claims
- 0588US9526777B2Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoproteinSULLIVAN NANCY J·Filed 2011·Granted Dec 27, 2016·7 cites·5 claims
- 0686US11306341B2Methods of culturing a mammalian cellGENZYME CORP·Filed 2015·Granted Apr 19, 2022·3 cites·13 claims
- 0786US8039606B2Seneca Valley virus based compositions and methods for treating diseaseNOVARTIS AG·Filed 2009·Granted Oct 18, 2011·6 cites·3 claims
- 0884US11602559B2HIV-1 Env fusion peptide immunogens and their useUS HEALTH·Filed 2017·Granted Mar 14, 2023·2 cites·16 claims
- 0984US2024294599A1Chimeric antigen receptors targeting g-protein coupled receptor and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1083US8753622B2Seneca valley virus based compositions and methods for treating diseaseHALLENBECK PAUL·Filed 2011·Granted Jun 17, 2014·5 cites·5 claims
- 1180US12145968B2Recombinant HIV-1 envelope proteins and their useUS HEALTH·Filed 2022·Granted Nov 19, 2024·0 cites·13 claims
- 1280US7638318B2Seneca Valley virus based compositions and methods for treating diseaseNORVARTIS AG·Filed 2006·Granted Dec 29, 2009·6 cites·9 claims
- 1378US12458691B2HIV-1 ENV fusion peptide immunogens and their useUS HEALTH·Filed 2023·Granted Nov 4, 2025·0 cites·20 claims
- 1478US2024424082A1Glycan-masked engineered outer domains of hiv-1 gp120 and their useTHE US SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES·Filed 2024·Application pending·0 cites
- 1576US11913013B2Chimpanzee adenoviral vector-based filovirus vaccinesUS GOV HEALTH & HUMAN SERVICES·Filed 2021·Granted Feb 27, 2024·0 cites·5 claims
- 1674US11820836B2Polypeptide and use thereofBGI SHENZHEN·Filed 2022·Granted Nov 21, 2023·0 cites·10 claims
- 1773US2009286860A1Method of using adenoviral vectors to induce an immune responseGENVEC INC·Filed 2009·Application pending·0 cites
- 1872US12053520B2Glycan-masked engineered outer domains of HIV-1 gp120 and their useUS HEALTH·Filed 2022·Granted Aug 6, 2024·0 cites·28 claims
- 1968US11390647B2Polypeptide and use thereofBGI SHENZHEN·Filed 2019·Granted Jul 19, 2022·0 cites·5 claims
- 2068US2024076228A13d glass-ceramic, preparation method therefor and application thereofCHONGQING AUREAVIA HI TECH GLASS CO LTD·Filed 2022·Application pending·0 cites
- 2168US2024317636A1Crystallized glass raw material, preparation method therefor and use thereofCHONGQING AUREAVIA HI TECH GLASS CO LTD·Filed 2022·Application pending·0 cites
- 2267US12486524B2Methods of culturing a mammalian cellGENZYME CORP·Filed 2022·Granted Dec 2, 2025·0 cites·5 claims
- 2367US11235056B2Glycan-masked engineered outer domains of HIV-1 gp120 and their useUS HEALTH·Filed 2018·Granted Feb 1, 2022·0 cites·30 claims
- 2467US2020149069A1Chimpanzee adenoviral vector-based filovirus vaccinesTHE GOVERNMENT OF THE US SECRETARY OF THE DEPARTMENT OF·Filed 2020·Application pending·0 cites
- 2564US10584355B2Chimpanzee adenoviral vector-based filovirus vaccinesUS GOV HEALTH & HUMAN SERVICES·Filed 2016·Granted Mar 10, 2020·0 cites·16 claims
- 2663US2025197455A1Base-covered hiv-1 envelope ectodomains and their useTTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVI·Filed 2023·Application pending·0 cites
- 2761US2007207166A1Method of Using Adenoviral Vectors to Induce an Immune ResponseGENVEC INC·Filed 2005·Application pending·0 cites
- 2861US2014348798A1Seneca valley virus based compositions and methods for treating diseaseNEOTROPIX INC·Filed 2014·Application pending·0 cites
- 2957US2024299510A1Antibody-guided pcsk9-mimicking immunogens lacking 9-residue sequence overlap with human proteinsUS HEALTH·Filed 2021·Application pending·0 cites
- 3057US2012302627A1Method of using adenoviral vectors to induce an immune responseNABEL GARY J·Filed 2012·Application pending·0 cites
- 3148US11136356B2Recombinant HIV-1 envelope proteins and their useUS HEALTH·Filed 2018·Granted Oct 5, 2021·0 cites·32 claims
- 3247US2022204950A1A new type of enzyme compositionBELIEF BIOMED LTD·Filed 2020·Application pending·0 cites
- 3346US2008003236A1Adenovirus fiber shaft composition and methods of useGENVEC INC·Filed 2007·Application pending·0 cites
- 3446US2008069836A1Method of using adenoviral vectors with increased immunogenicity in vivoUS HEALTH·Filed 2007·Application pending·0 cites
- 3543US2006286121A1Adenoviral vector-based vaccinesGALL JASON G D·Filed 2006·Application pending·0 cites
- 3641US9701718B2Adenovirus serotype 26 and serotype 35 filovirus vaccinesSULLIVAN NANCY J·Filed 2011·Granted Jul 11, 2017·0 cites·15 claims
- 3740US2012066476A1Micro-operation processing system and data writing method thereofCHENG CHENG TANG·Filed 2011·Application pending·0 cites
- 3839US2003104625A1Novel oncolytic adenoviral vectorsFiled 2002·Application pending·0 cites
- 3933US2003166601A1Novel colloid synthetic vectors for gene therapyFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cheng Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →